Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
Business Wire•28/09/2026•06:45 ET
0
Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
Data across 45 abstracts will highlight new evidence for established medicines, including PADCEV and TALZENNA, and promising late-stage pipeline candidates such as atirmociclib and tivunatamig (PF’4404)
Get started
Create a free account to read the full story and Whiz Insights.